Evidence map›Paper›PMID 33788178›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2021

The use of denaturing solution as collection and transport media to improve SARS-CoV-2 RNA detection and reduce infection of laboratory personnel.

Alex F Carvalho, Raissa P Rocha, Andreza P Gonçalves, Thaís B S Silva, Hugo I Sato, Larissa Vuitika, Flavia F Bagno, Sarah A R Sérgio, Maria M Figueiredo, Ronaldo B Martins and 6 more

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Effectiveness of TRIzol in Inactivating Animal Pathogens.Applied biosafety : journal of the American Biological Safety Association · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alex F CarvalhoCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Raissa P RochaCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Andreza P GonçalvesCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Thaís B S SilvaCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Hugo I SatoCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Larissa VuitikaCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Flavia F BagnoCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Sarah A R SérgioCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Maria M FigueiredoCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Ronaldo B MartinsVirology Research Center, Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, São Paulo, 14040900, Brazil.
Juliano P SouzaVirology Research Center, Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, São Paulo, 14040900, Brazil.
Eurico ArrudaVirology Research Center, Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, São Paulo, 14040900, Brazil.
Ana P S M FernandesCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Pedro A AlvesCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Santuza M R TeixeiraCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil.
Flavio G da FonsecaCentro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, CEP: 31210-260, Brazil. fdafonseca@icb.ufmg.br.ORCID http://orcid.org/0000-0002-1416-8694

Funding

Medical Research Council MR/P027989/1
6 · The paper itself

Abstract

Accurate testing to detect SARS-CoV-2 RNA is key to counteract the virus spread. Nonetheless, the number of diagnostic laboratories able to perform qPCR tests is limited, particularly in developing countries. We describe the use of a virus-inactivating, denaturing solution (DS) to decrease virus infectivity in clinical specimens without affecting RNA integrity. Swab samples were collected from infected patients and from laboratory personnel using a commercially available viral transport solution and the in-house DS. Samples were tested by RT-qPCR, and exposure to infective viruses was also accessed by ELISA. The DS used did not interfere with viral genome detection and was able to maintain RNA integrity for up to 16 days at room temperature. Furthermore, virus loaded onto DS were inactivated, as attested by attempts to grow SARS-CoV-2 in cell monolayers after DS desalt filtration to remove toxic residues. The DS described here provides a strategy to maintain diagnostic accuracy and protects diagnostic laboratory personnel from accidental infection, as it has helped to protect our lab crew.

Indexed as

COVID-19COVID-19 TestingDiagnostic Tests, RoutineGenome, ViralHumansProtein DenaturationReal-Time Polymerase Chain ReactionRNA StabilityRNA, ViralSARS-CoV-2Specimen HandlingRNA, ViralCOVID-19 diagnosticsLaboratory personnelRNA integritySampling solutionSARS-CoV-2

Identifiers

PMID33788178
PMCPMC8010291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.